Medical dictionary
Medical terminology normalized via MeSH, ICD-11, SNOMED CT.
62,341 terms indexed
structure in first source
structure in first source
structure in first source
structure in first source
has both neuroprotective and neurotrophic activities
structure in first source
structure in first source
structure in first source
- C5776092-(ethylthio)ethyl 6-(furan-2-yl)-3-methyl-4-oxo-4,5,6,7,tetrahydro-1H-indole-2-carboxylateMeSH
an antitubulin agent; structure in first source
structure in first source
isolated from Indigofera gerardiana; structure in first source
from the endophytic Colletotrichum sp. of Ginkgo biloba; structure in first source
structure in first source
structure in first source
structure in first source
a microtubule inhibitor with antineoplastic activity; structure in first source
structurein first source
from Pseudoalteromonas rubra; structure in first source
structure in first source
structure in first source
structure in first source
antioxidative and antiproliferative; structure in first source
structure in first source
structure in first source
has antineoplastic activity; structure in first source
has antineoplastic activity; structure in first source
has antineoplastic activity; structure in first source
from the aerial parts of Macrothelypteris torresiana; structure in first source
structure in first source
An enzyme involved in the biosynthesis of isoleucine and valine. It converts 2-acetolactate into 3-hydroxy-2-oxo-isovalerate. Also acts on 2-hydroxy-2-acetobutyrate to form 2-hydroxy-2-oxo-3-methylvalerate. EC 5.4.99.3.
A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the aryl hydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. It is used to study the carcinogenicity and mutagenicity of aromatic amines.
The D-enantiomer is a potent and specific antagonist of NMDA glutamate receptors (RECEPTORS, N-METHYL-D-ASPARTATE). The L form is inactive at NMDA receptors but may affect the AP4 (2-amino-4-phosphonobutyrate; APB) excitatory amino acid receptors.
A PYRIDOXAL PHOSPHATE containing enzyme that catalyzes the transfer of amino group of L-2-aminoadipate onto 2-oxoglutarate to generate 2-oxoadipate and L-GLUTAMATE.
A metabolite in the principal biochemical pathway of lysine. It antagonizes neuroexcitatory activity modulated by the glutamate receptor, N-METHYL-D-ASPARTATE; (NMDA).
A purine that is an isomer of ADENINE (6-aminopurine).
2-Chloroadenosine. A metabolically stable analog of adenosine which acts as an adenosine receptor agonist. The compound has a potent effect on the peripheral and central nervous system.
A chemical reagent that reacts with and modifies chemically the tryptophan portion of protein molecules. Used for 'active site' enzyme studies and other protein studies. Sometimes referred to as Koshland's reagent.
Simple amine found in the brain. It may be modulator of sympathetic functions. Its derivatives are adrenergic agonists and antagonists. It is also used in chemical industry.
An enzyme that catalyzes the first step in the biosynthetic pathway to LEUCINE, forming isopropyl malate from acetyl-CoA and alpha-ketoisovaleric acid. This enzyme was formerly listed as EC 4.1.3.12.
A powerful herbicide used as a selective weed killer.
mutation in ACADSB
an antineoplastic agent; structure in first source
protects C. elegans from bacterial infection
has antineoplastic activity
A naphthalene derivative with carcinogenic action.
isolated from raw beans of Coffea L.; structure in first source
from Echinacea purpurea; structure in first source
antidiabetic agent isolated from the Japanese red maple Acer pycnanthum; structure in first source
from Tinospora crispa vines; structure in first source